The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomised, controlled, multicentre trial of imiquimod versus radiotherapy for lentigo maligna.
 
Angela M Hong
Stock and Other Ownership Interests - BeiGene
Consulting or Advisory Role - Roche (I); Telix Pharmaceuticals
Travel, Accommodations, Expenses - Roche (I)
 
Serigne N Lo
No Relationships to Disclose
 
Gerald B Fogarty
Employment - Icon Cancer Center
Stock and Other Ownership Interests - GenesisCare
Consulting or Advisory Role - Atomic Oncology; L'Oreal
Research Funding - Sanofi
 
Jonathan Stretch
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Pablo Fernandez Penas
Consulting or Advisory Role - Abbvie; Amgen; Boehringer Ingelheim
Research Funding - Pfizer (Inst)
Other Relationship - Abbvie (Inst); Akaal (Inst); Akeso Biopharma (Inst)
 
Richard CW Martin
No Relationships to Disclose
 
Matthew C Foote
Employment - Icon Cancer Care
Leadership - Icon Cancer Center
Stock and Other Ownership Interests - Icon Cancer Center
Honoraria - Elekta; Varian Medical Systems
Consulting or Advisory Role - Elekta; Varian Medical Systems
Speakers' Bureau - Elekta; Varian Medical Systems
Research Funding - Elekta
 
Hans Peter Soyer
Stock and Other Ownership Interests - E-derm-consult GmBH; Molemap NZ LTd
Consulting or Advisory Role - Blaze Bioscience (Inst); Canfield Scientific (Inst)
 
Jeremy Ruben
No Relationships to Disclose
 
Victoria Mar
Honoraria - Bristol Myers Squibb (Inst); Bristol Myers Squibb (Inst); Bristol-Myers Squibb; Janssen (Inst); Merck (Inst); Novartis
Consulting or Advisory Role - L'Oreal (Inst); MSD (Inst)
Research Funding - MoleMap (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; L'Oreal
 
Lilian Rocha
No Relationships to Disclose
 
Christopher Wratten
No Relationships to Disclose
 
Helena Collgros
No Relationships to Disclose
 
Amanda Regio Pereira
No Relationships to Disclose
 
Bruna Melhoranse Gouveia
No Relationships to Disclose
 
Richard A Scolyer
Employment - Sydney Local Health District / Royal Prince Alfred Hospital
Leadership - Melanoma Institute Australia
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb GesmbH (Austria); Bristol-Myers Squibb SA (Switzerland); Evaxion Biotech; GlaxoSmithKline; IO Biotech; Merck Sharp & Dohme; metaoptima; MSD Sharp & Dohme (Australia) Pty Limited; Myriad Genetics; NeraCare GmbH; Novartis; Novartis; Novartis; Novartis; Provectus Biopharmaceuticals; QBiotics; Roche
Research Funding - Melanoma Research Alliance (MRA); National Health and Medical Research Council; National Health and Medical Research Council; Tour de Cure
 
Madeleine T King
Research Funding - Abbvie; Bristol-Myers Squibb
 
Pascale Guitera
Honoraria - metaoptima
Research Funding - L'oreal (Inst)
Travel, Accommodations, Expenses - La roche Posay